Delivery Order SPE2DB20D3103-SPE2DB23FM1E4

Award Date 1/10/23
Potential Completion Date 1/11/23
Potential Value $1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Chlorothiazide Sodium 500 mg vials. The award amount is $3,739.78 and has an ultimate completion date of March 10, 2025. The contract is a Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency, and is a Firm Fixed Price contract type. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award, with ID SPE2DB22D3301|SPE2DB23FY6VF, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,537.43 firm fixed-price delivery order is for the supply of 400 milliequivalents per 100 milliliters of sodium chloride, a critical medical product. The contract has an ultimate completion date of May 4, 2023. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $1,456.75 Firm Fixed Price Delivery Order is for the supply of 4560815825 CHLORDIAZEPOXIDE-CLIDINIUM CAP 100S, a pharmaceutical product. The contract has an ultimate completion date of May 4, 2023. The award is not associated with any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999...
This federal contract award, with an ID of SPE2DB25D7056|SPE2DB25FTMCP, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,539.77 delivery order contract is for the supply of 4,567,572,950 units of the medication Chlorthalidone 50 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of March 17, 2025. This award is part of a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $14,243.99 firm-fixed-price delivery order is for the supply of 4,563,974,946 units of sodium chloride 10 ml vials. The award has an ultimate completion date of April 11, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,935.81 firm fixed-price delivery order is for the supply of 4555797770 units of 0.9% sodium chloride intravenous solution in 100 mL flexible containers. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award, valued at $35,127.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB25FN0BA) under an Indefinite Delivery Contract (SPE2DB22D1200) held by Amerisourcebergen with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. The award is for the supply of 4567039849 -...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,199.80 fixed-price delivery order is for the supply of 500 ml sodium chloride 0.9% solution, with a performance period through May 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company owned by Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price, valued at $3,027.28, for the supply of a medical product, specifically 4560774400 ! SOL IV 0.9% NACL 50ML 1 DS PWDR DRG VL. The contract has a period of performance through May 2, 2023. This award is not associated with a set-aside designation, indicating open...
This federal contract award to Amerisourcebergen Drug Corp, valued at $2,067.70, is a Delivery Order issued by the Defense Logistics Agency (DLA) under the company's existing Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract is for the delivery of sodium chloride 0.9% solution in 100mL containers, a critical medical supply used in various healthcare settings. As an open competition award with no set-aside designation, Amerisourcebergen, a major pharmaceutical distributor...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FM1E4
    Delivery Order

This federal contract award, SPE2DB20D3103|SPE2DB23FM1E4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Chlorothiazide Sodium 500 mg vials. The $1,030.01 fixed-price delivery order has a completion date of January 11, 2023.

Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical medical commodities, to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating it was open competition.

Generated 2/27/25, 12:40 PM